Pete Tsiampas

Pete Tsiampas has a background spanning healthcare strategy, transaction advisory, and life sciences commercialization. His expertise bridges clinical insight, scientific rigor, and financial strategy within healthcare and medtech markets. He has supported diligence processes, reimbursement assessments, and growth strategy development for provider organizations, healthcare services companies, and life sciences innovators.

Pete has experience collaborating with physicians, researchers, and executive teams to translate complex clinical, regulatory, and operational information into actionable strategic recommendations. His work frequently focuses on healthcare services, physician practice dynamics, and technology-enabled care delivery models, with a particular emphasis on value creation through operational optimization and transaction strategy.

Prior to joining Acuvance Coker, Pete worked across life sciences and healthcare innovation environments where he supported commercialization strategy, market access planning, and regulatory-aligned product development initiatives. He brings experience in market sizing, competitive landscape analysis, and revenue forecasting for emerging medical technologies, while supporting cross-functional initiatives spanning clinical development, market access, and investor diligence preparation.